Structural break signals
RYTM qualifies for the Amber List on decline depth.
The structural read
What price action says about RYTM.
RYTM qualifies for the Amber List on decline depth — down -23.4% from its rolling 252-day high.
Cross-confirmation: also showing 4/5 bearish time frames.
Alongside that decline, our proprietary engine has flagged a confirmed bullish structural signal on one or more time frames — moderate or strong time-frame-continuity (TFC) alignment — so the ticker also carries a Recovering badge. The two readings coexist: the tier tells you how deep the damage is, the Recovering badge tells you whether momentum may be turning. Recovering is not a buy signal; it's a structural read.
Upstream TFC read: moderate alignment, current phase daily. Last bar types — daily 1 (red), weekly 1 (green), monthly 3 (green).
Earnings on file: 2026-05-05. Tiering is unaffected by earnings dates — listings reflect price structure only.
52-week range
Sector context · Healthcare
182 other Healthcare tickers are on Broken Stocks.
Worst in sector: OPRX (-76.7%). Least-bad: ANIP (-20.0%). See all Healthcare listings →
Questions about RYTM
What people ask.
Why is RYTM on Broken Stocks?
RYTM qualifies for the Amber List on decline depth. It is down -23.4% from its rolling 252-day high of $122.20, set on 2025-12-11 — 154d ago. It additionally carries a Recovering badge — see below.
What does the Recovering badge mean for RYTM?
Recovering means our proprietary engine has flagged a confirmed bullish structural signal on one or more time frames (moderate or strong time-frame continuity). It coexists with the decline tier — RYTM is still Amber List because the rolling-252-day decline hasn't healed, but a bullish setup has formed inside that decline. The two readings answer different questions: the tier tells you how deep the damage is; the Recovering badge tells you whether momentum may be turning. It's not a buy recommendation.
Is RYTM a falling knife?
No. The falling-knife label usually implies a steep, severe drop — typically 30% or more from a fresh high. RYTM is down -23.4% from its 52-week high, which qualifies for the Watch tier but is shallower than the falling-knife pattern. It's an early-stage decline rather than a sharp breakdown.
Is RYTM a buy?
Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.
Where is RYTM trading inside its 52-week range?
At $93.63, RYTM sits 57.3% of the way from its 52-week low ($55.31) to its 52-week high ($122.20). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.
How fast has RYTM been declining?
The current 23.4% decline accrued over 154d, which annualizes to roughly -55.5% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.
How does RYTM compare to its sector?
There are 182 other Healthcare tickers on Broken Stocks: 93 Red, 42 Amber, 47 Watch, with 54 showing recovering structural signals. Median sector decline is -35.8% — RYTM's decline is shallower than the sector median.
Does RYTM's earnings date affect its tier?
No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-05-05) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.